Bioptamers works on the development and marketing of a new class of personalized therapies. Key elements of their strategy are the collaboration with universities, private companies, and hospitals to accelerate the translation of their expertise into improvements in clinical outcomes for cancer patients.

Biotechnology

Bioptamers

Erika Molina

Emerson Moretto

The executive team at Bioptamers has a history of experience in the fields of tissue engineering, 3D printing, prosthetics, computer engineering, and biochemistry. They have also been involved in research at various institutions, including the University of Bonn, Leipzig University, and the Cell and Molecular Therapy Center (Nucel).

CEO and Executive Team

About

Team members

Other teams at Bioptamers

Leadership Team